Recently, Yu et al. [28] showed that MnTE-2-PyP5+ treatment reversed cell phenotypes induced by TGF-β in colon cancer cells and significantly reduced the expression of mesenchymal markers but maintained epithelial marker expression. The gene discussed is TGFB1; the disease is malignant colon neoplasm.